Home › NCT07449195
A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors
Recruiting
Ocular Imaging for Monitoring of Ocular Tumor Disease
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Age ≥18 years. * At least 1 eye that has an intraocular or ocular surface tumor. * The presence of a natural crystalline lens or intraocular lens. * Pupils that can dilate up to at least 3 mm in the study eyes. * The absence of opaque natural crystalline lenses or the presence of any ocular disease that prevents the view of the retina for imaging. * Patients must be able to fixate on the imaging target. * Patients must be able to sit still for a period of time (approximately 2 minutes). Exclusion Criteria: * Does not meet ALL of the above conditions
About the study
The purpose of this study is to compare two devices used for optical coherence tomography (OCT). OCT is a noninvasive imaging (scanning) method that uses reflected light to create pictures of the back of the eye, and doctors can use OCT to detect and monitor different types of cancer
What is being tested
- Intalight Dream OCT (diagnostic test)
- Heidelberg Spectralis OCT (diagnostic test)
Sponsor: Memorial Sloan Kettering Cancer Center · Participants: 60 · Started: Feb 27, 2026
Contact the study team
- Jasmine Francis, MD · Phone: 212-639-7266
- David Abramson, MD · Phone: 212-639-7232
Official record on ClinicalTrials.gov — NCT07449195
Locations in the U.S.
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.